Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (7): 447-448.
ZHAO Ruiping, LI Chengmin* ,DU Yanhong
Received:
2019-08-06
Revised:
2019-08-06
Online:
2019-07-20
Published:
2019-08-06
CLC Number:
ZHAO Ruiping, LI Chengmin ,DU Yanhong. One Case of Exfoliative Keratosis Induced by Vancomycin Hydrochloride for Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(7): 447-448.
[1] 国家药典委员会.临床用药须知[M]. 化学药和生物制品卷(2005版). 北京:化学工业出版社, 2005:545-547. [2] 谭慧心. 万古霉素20012013年不良反应报道文献的分析[J].现代药物与临床, 2013, 28(4):598-601. [3] 赵春丽,裴航,赵保红,等. 95例万古霉素不良反应文献分析[J]. 中国药物警戒, 2018, 15(6):354-358. [4] 王素红. 中西医结合治疗剥脱性角质松解症临床观察[J].现代中西医结合杂志,2008,17(18):2838. [5] Y.Y. Chang,J. van der Velden,G. van der Wier, et al.Keratolysis exfoliativa (dyshidrosis lamellose sicca):a distinct peeling entity[J].BritishJournal of Dematology,2012,167(5):1076-1084. [6] 刘昱. 中药黄芪口服致剥脱性角质松解症1例[J]. 中国中医急症, 2013, 22(7):1251. [7] 谢福军,陈艳秋. 罗格列酮相关的剥脱性角质松解症[J].药物不良反应杂志, 2009,11(1):50-51. [8] 黄光寿. 吡哌酸引起剥脱性角质松解症1例[J].海峡药学,1994(2):34. [9] 胡萍, 徐传新, 胡燕,等.左卡尼汀注射液致剥脱性角质松解症1例[J].中国医院药学杂志, 2013,33(3):256. [10] 汤晟凌,周慧萍,刘云,等.万古霉素不良反应报道文献分析[J]. 中国药业,2007(16):51-52. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||